Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Baldry Mark. Insider active across 1 company, notably X4 Pharmaceuticals, Inc. Cumulatively, 8 disclosures have been recorded. Split: 2 buys · 2 sells. Total volume traded: €29k. History available since 31 October 2023. The latest transaction was filed on 16 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Baldry Mark has 7 filings in total. In the 7 most recent filings we hold, related to X4 Pharmaceuticals, Inc, the reported buy and sell amounts are EUR 15773 and EUR 13005, respectively, over the period from 2023-11-02 to 2025-05-20. Their primary role is not provided, and the most common transaction nature is Attribution.